Katri Koli

2.9k total citations
56 papers, 2.4k citations indexed

About

Katri Koli is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Katri Koli has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in Katri Koli's work include TGF-β signaling in diseases (27 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Neonatal Respiratory Health Research (11 papers). Katri Koli is often cited by papers focused on TGF-β signaling in diseases (27 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Neonatal Respiratory Health Research (11 papers). Katri Koli collaborates with scholars based in Finland, United States and Germany. Katri Koli's co-authors include Jorma Keski‐Oja, Marjukka Myllärniemi, Vuokko L. Kinnula, Carlos L. Arteaga, Harald von Melchner, Kaisa Salmenkivi, Juha Saharinen, Anja Sterner‐Kock, Frank Wempe and Outi Leppäranta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Katri Koli

56 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katri Koli Finland 27 1.2k 730 348 343 324 56 2.4k
John G. Harpel United States 11 1.2k 1.0× 309 0.4× 203 0.6× 353 1.0× 271 0.8× 21 2.1k
Veronica Stellmach United States 20 1.8k 1.5× 373 0.5× 254 0.7× 408 1.2× 610 1.9× 29 2.9k
Giovanni Ligresti United States 31 1.2k 1.0× 639 0.9× 119 0.3× 411 1.2× 295 0.9× 59 2.4k
Maarten van Dinther Netherlands 25 1.6k 1.4× 391 0.5× 175 0.5× 523 1.5× 290 0.9× 44 2.3k
Cristina Colarossi Italy 26 1.1k 0.9× 374 0.5× 191 0.5× 604 1.8× 461 1.4× 80 2.3k
Fumiko Itoh Japan 26 2.2k 1.8× 281 0.4× 215 0.6× 559 1.6× 279 0.9× 56 3.0k
Chengsen Xue United States 9 1.9k 1.6× 803 1.1× 274 0.8× 856 2.5× 383 1.2× 13 3.7k
Michael E. Engel United States 20 1.4k 1.2× 779 1.1× 103 0.3× 565 1.6× 216 0.7× 65 2.5k
Matthias C. Kugler United States 15 908 0.8× 1.2k 1.6× 89 0.3× 368 1.1× 371 1.1× 26 2.4k
Kouki Inai Japan 32 1.2k 1.0× 1.0k 1.4× 128 0.4× 868 2.5× 457 1.4× 104 3.1k

Countries citing papers authored by Katri Koli

Since Specialization
Citations

This map shows the geographic impact of Katri Koli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katri Koli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katri Koli more than expected).

Fields of papers citing papers by Katri Koli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katri Koli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katri Koli. The network helps show where Katri Koli may publish in the future.

Co-authorship network of co-authors of Katri Koli

This figure shows the co-authorship network connecting the top 25 collaborators of Katri Koli. A scholar is included among the top collaborators of Katri Koli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katri Koli. Katri Koli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saraswat, Mayank, Sakari Joenväärä, Eva Sutinen, et al.. (2020). Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways. Scientific Reports. 10(1). 7787–7787. 13 indexed citations
2.
Paajanen, Juuso, Ilkka Ilonen, Eva Sutinen, et al.. (2019). Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy. Clinical Lung Cancer. 21(3). e142–e150. 24 indexed citations
3.
Salomaa, Eija‐Riitta, Ulla Hodgson, Riitta Kaarteenaho, et al.. (2019). Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry. ERJ Open Research. 5(3). 170–2018. 75 indexed citations
4.
Noda, Kazuo, Branka Dabovic, Kyoko Takagi, et al.. (2013). Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. Proceedings of the National Academy of Sciences. 110(8). 2852–2857. 109 indexed citations
5.
Loukovaara, Sirpa, Alexandra Robciuc, Juha M. Holopainen, et al.. (2013). Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGF beta 1 in diabetic eyes undergoing vitrectomy. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
6.
Leppäranta, Outi, Jussi Tikkanen, Maxim M. Bespalov, Katri Koli, & Marjukka Myllärniemi. (2012). Bone Morphogenetic Protein–Inducer Tilorone Identified by High-Throughput Screening Is Antifibrotic In Vivo. American Journal of Respiratory Cell and Molecular Biology. 48(4). 448–455. 27 indexed citations
7.
Myllärniemi, Marjukka, et al.. (2012). Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling. Journal of Cellular Biochemistry. 113(7). 2234–2247. 23 indexed citations
8.
Leppäranta, Outi, Carla Sens, Kaisa Salmenkivi, et al.. (2012). Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung. Cell and Tissue Research. 348(3). 491–503. 58 indexed citations
9.
Loukovaara, Sirpa, Alexandra Robciuc, Juha M. Holopainen, et al.. (2012). Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy. Acta Ophthalmologica. 91(6). 531–539. 83 indexed citations
10.
Järvinen, Päivi M., Marjukka Myllärniemi, Hester Liu, et al.. (2011). Cysteine‐rich protein 1 is regulated by transforming growth factor‐β1 and expressed in lung fibrosis. Journal of Cellular Physiology. 227(6). 2605–2612. 12 indexed citations
11.
Lhota, Filip, et al.. (2010). Independent regulation of short and long forms of latent TGF‐β binding protein (LTBP)‐4 in cultured fibroblasts and human tissues. Journal of Cellular Physiology. 223(3). 727–736. 35 indexed citations
12.
Koli, Katri, Marjukka Myllärniemi, Jorma Keski‐Oja, & Vuokko L. Kinnula. (2007). Transforming Growth Factor- β Activation in the Lung: Focus on Fibrosis and Reactive Oxygen Species. Antioxidants and Redox Signaling. 10(2). 333–342. 140 indexed citations
13.
Myllärniemi, Marjukka, Pamela Lindholm, Corrine R. Kliment, et al.. (2007). Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 177(3). 321–329. 152 indexed citations
14.
Koli, Katri, Marjukka Myllärniemi, Kirsi Vuorinen, et al.. (2006). Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis. American Journal Of Pathology. 169(1). 61–71. 137 indexed citations
15.
Koli, Katri, et al.. (1997). Blockade of Transforming Growth Factor-β Signaling Does Not Abrogate Antiestrogen-induced Growth Inhibition of Human Breast Carcinoma Cells. Journal of Biological Chemistry. 272(13). 8296–8302. 34 indexed citations
16.
Koli, Katri & Carlos L. Arteaga. (1996). Complex role of tumor cell transforming growth factor (TGF)-βs on breast carcinoma progression. Journal of Mammary Gland Biology and Neoplasia. 1(4). 373–380. 27 indexed citations
17.
Keski‐Oja, Jorma, Katri Koli, Jouko Lohi, Juha Saharinen, & Jussi Taipale. (1995). Association of Latent Transforming Growth Factor-.BETA. to Fibroblast Extracellular Matrix-An Insight to Proteolytic Activation.. Trends in Glycoscience and Glycotechnology. 7(36). 277–289. 3 indexed citations
18.
Koli, Katri & Jorma Keski‐Oja. (1993). Vitamin D 3 and Calcipotriol Enhance the Secretion of Transforming Growth Factor-β1 and -β2 in Cultured Murine Keratinocytes. Growth Factors. 8(2). 153–163. 39 indexed citations
19.
Koli, Katri & Jorma Keski‐Oja. (1992). Cellular Senescence. Annals of Medicine. 24(5). 313–318. 12 indexed citations
20.
Keski‐Oja, Jorma, Katri Koli, Jouko Lohi, & Marikki Laiho. (1991). Growth Factors in the Regulation of Plasminogen-Plasmin System in Tumor Cells. Seminars in Thrombosis and Hemostasis. 17(3). 231–239. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026